Skip to content
News & Events
Stay up-to-date with the latest RemeGen news, events, and publications.
Expanded Access Policy for Investigational Product RC48
RemeGen Co., Ltd. Announced New RC48-ADC Data in Patients with Advanced Gastric Cancer at ASCO
RemeGen Announces US FDA Clearance of IND Application to Initiate Phase II Clinical Trial in Urothelial Cancer
View all news
For media inquiries, please contact Jennifer Gordon at